As Jnj (Put) (JNJ) Market Value Declined, Shareholder Integral Derivatives Trimmed by $486,500 Its Position; As Express Scripts Hldg Co (ESRX) Stock Value Declined, Kensico Capital Management Has Trimmed Position

April 20, 2018 - By Adrian Mccoy

Express Scripts Holding Company (NASDAQ:ESRX) Logo

Michael Lowenstein decreased its stake in Express Scripts Hldg Co (ESRX) by 68.12% based on its latest 2017Q4 regulatory filing with the SEC. Kensico Capital Management Corp sold 1.44M shares as the company’s stock declined 5.58% with the market. The hedge fund run by Michael Lowenstein held 675,000 shares of the medical and nursing services company at the end of 2017Q4, valued at $50.38 million, down from 2.12 million at the end of the previous reported quarter. Kensico Capital Management Corp who had been investing in Express Scripts Hldg Co for a number of months, seems to be less bullish one the $41.22B market cap company. The stock decreased 0.49% or $0.36 during the last trading session, reaching $73.4. About 1.09 million shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has risen 8.93% since April 20, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Integral Derivatives Llc decreased its stake in Jnj (Put) (JNJ) by 9.92% based on its latest 2017Q4 regulatory filing with the SEC. Integral Derivatives Llc sold 3,500 shares as the company’s stock declined 9.21% with the market. The institutional investor held 31,800 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $4.44 million, down from 35,300 at the end of the previous reported quarter. Integral Derivatives Llc who had been investing in Jnj (Put) for a number of months, seems to be less bullish one the $339.38 billion market cap company. The stock decreased 0.82% or $1.04 during the last trading session, reaching $126.51. About 4.21M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 20, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Analysts await Express Scripts Holding Company (NASDAQ:ESRX) to report earnings on May, 2 after the close. They expect $1.76 earnings per share, up 32.33% or $0.43 from last year’s $1.33 per share. ESRX’s profit will be $988.29 million for 10.43 P/E if the $1.76 EPS becomes a reality. After $2.16 actual earnings per share reported by Express Scripts Holding Company for the previous quarter, Wall Street now forecasts -18.52% negative EPS growth.

Investors sentiment increased to 0.69 in 2017 Q4. Its up 0.07, from 0.62 in 2017Q3. It improved, as 68 investors sold ESRX shares while 407 reduced holdings. 111 funds opened positions while 216 raised stakes. 479.40 million shares or 1.52% less from 486.80 million shares in 2017Q3 were reported. Veritas Asset Mgmt Llp holds 8.98 million shares or 5.21% of its portfolio. Fisher Asset Mgmt Limited Liability Com reported 0.03% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Stevens First Principles Invest has 238 shares. 12,276 are owned by Northeast Invest Mngmt. Brandywine reported 2,849 shares. Nelson Van Denburg & Campbell Wealth Grp Limited Liability Corporation holds 16,340 shares. Convergence Inv Limited Liability accumulated 0.54% or 53,526 shares. Legacy Private Tru Comm owns 8,516 shares or 0.07% of their US portfolio. Ckw Financial Group reported 1,800 shares. Fred Alger Mgmt Inc reported 0% in Express Scripts Holding Company (NASDAQ:ESRX). Lourd Capital Limited Liability Corp invested in 0.02% or 3,459 shares. Louisiana-based Price Management Inc has invested 0.61% in Express Scripts Holding Company (NASDAQ:ESRX). Ballentine Llc owns 7,028 shares. Capital Fund Management holds 0.05% or 112,717 shares in its portfolio. Commonwealth Comml Bank Of Australia owns 300,661 shares or 0.22% of their US portfolio.

Among 25 analysts covering Express Scripts (NASDAQ:ESRX), 8 have Buy rating, 3 Sell and 14 Hold. Therefore 32% are positive. Express Scripts had 66 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Robert W. Baird given on Friday, December 15. The stock has “Market Perform” rating by Leerink Swann on Wednesday, March 23. The firm has “Sell” rating given on Tuesday, January 30 by Bernstein. As per Thursday, March 29, the company rating was maintained by William Blair. Morgan Stanley downgraded Express Scripts Holding Company (NASDAQ:ESRX) rating on Monday, June 20. Morgan Stanley has “Underweight” rating and $70 target. As per Monday, February 22, the company rating was downgraded by Deutsche Bank. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, January 31. The firm has “Market Perform” rating by Bernstein given on Wednesday, December 6. The firm earned “Hold” rating on Thursday, December 14 by RBC Capital Markets. The firm has “Neutral” rating given on Thursday, October 6 by UBS.

Kensico Capital Management Corp, which manages about $7.43B and $5.02B US Long portfolio, upped its stake in Symantec Corp (NASDAQ:SYMC) by 284,773 shares to 7.15 million shares, valued at $200.62 million in 2017Q4, according to the filing. It also increased its holding in Olin Corp (NYSE:OLN) by 50,000 shares in the quarter, for a total of 7.85M shares, and has risen its stake in Cheniere Energy Inc (NYSEMKT:LNG).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 95 analyst reports since August 7, 2015 according to SRatingsIntel. Piper Jaffray maintained the stock with “Hold” rating in Tuesday, July 18 report. BMO Capital Markets maintained the stock with “Buy” rating in Monday, July 10 report. Societe Generale initiated the shares of JNJ in report on Wednesday, April 6 with “Hold” rating. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Jefferies on Thursday, July 14. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, June 13 with “Buy” rating. The rating was maintained by Barclays Capital with “Overweight” on Wednesday, April 20. JP Morgan upgraded Johnson & Johnson (NYSE:JNJ) on Monday, May 15 to “Overweight” rating. Atlantic Securities initiated the stock with “Neutral” rating in Friday, December 18 report. The firm has “Buy” rating by Cowen & Co given on Friday, October 6. Citigroup initiated Johnson & Johnson (NYSE:JNJ) on Monday, September 25 with “Hold” rating.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity.

Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.04, from 0.83 in 2017Q3. It increased, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Chase Inv Counsel Corporation invested in 1,960 shares. Beaumont Ltd Limited Liability Company stated it has 151,267 shares or 2.48% of all its holdings. Schnieders Capital Ltd Liability Com, California-based fund reported 57,643 shares. Hartford Investment Mngmt reported 599,203 shares. De Burlo Grp Inc Inc holds 1.78% or 62,950 shares in its portfolio. Cornerstone Capital reported 156,194 shares. Sfe Counsel has invested 1.26% in Johnson & Johnson (NYSE:JNJ). Signature Fin has invested 0.41% of its portfolio in Johnson & Johnson (NYSE:JNJ). Fukoku Mutual Life Ins reported 0.24% in Johnson & Johnson (NYSE:JNJ). Aviance Cap Lc holds 0% or 271 shares in its portfolio. Grimes holds 0.57% in Johnson & Johnson (NYSE:JNJ) or 42,225 shares. Timber Creek Mgmt Ltd Company stated it has 0.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). Inverness Counsel Limited New York has invested 0.97% in Johnson & Johnson (NYSE:JNJ). Convergence Inv Ltd Llc invested in 0.09% or 4,654 shares. Piedmont Investment Advisors Ltd invested in 2.03% or 723,547 shares.

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>